Fully synthetic platform to rapidly generate tetravalent bispecific nanobody–based immunoglobulins
Proceedings of the National Academy of Sciences · 13.06.2023 · 120 (24)
DOI: 10.1073/pnas.2216612120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 05.06.2023. Verfasst von Laetitia Misson Mindrebo und 21 weiteren Autor:innen. Beteiligte Einrichtung: International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037. Hauptthemen laut MEDLINE: Single-Domain Antibodies, COVID-19. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIGMS NIH HHS, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Nanobodies bind a target antigen with a kinetic profile similar to a conventional antibody, but exist as a single heavy chain domain that can be readily multimerized to engage antigen via multiple interactions. Presently, most nanobodies are produced by immunizing camelids; however, platforms for animal-free production are growing in popularity. Here, we describe the development of a fully synthetic nanobody library based on an engineered human V H 3-23 variable gene and a multispecific antibody-like format designed for biparatopic target engagement. To validate our library, we selected nanobodies against the SARS-CoV-2 receptor–binding domain and employed an on-yeast epitope binning strategy to rapidly map the specificities of the selected nanobodies. We then generated antibody-like molecules by replacing the V H and V L domains of a conventional antibody with two different nanobodies, designed as a molecular clamp to engage the receptor-binding domain biparatopically. The resulting bispecific tetra-nanobody immunoglobulins neutralized diverse SARS-CoV-2 variants with potencies similar to antibodies isolated from convalescent donors. Subsequent biochemical analyses confirmed the accuracy of the on-yeast epitope binning and structures of both individual nanobodies, and a tetra-nanobody immunoglobulin revealed that the intended mode of interaction had been achieved. This overall workflow is applicable to nearly any protein target and provides a blueprint for a modular workflow for the development of multispecific molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.
- International AIDS Vaccine Initiative, New York, NY 10004.
- Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.
- Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037.
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
- Department of Bioengineering, Stanford University, Stanford, CA 94305.
ORCID-Profile: Laetitia Misson Mindrebo, Hejun Liu, Gabriel Ozorowski, Quoc Tran, Jordan Woehl, Jessica M Smith, Fangzhu Zhao, Oliver Limbo, Megan Verma, Jingjia Liu, Robyn L Stanfield, Xueyong Zhu, Po-Ssu Huang, Dennis R Burton, Andrew B Ward, Ian A Wilson, Joseph G Jardine
Förderung
- Wellcome Trust
- NIGMS NIH HHS
- Bill and Melinda Gates Foundation
Zitieren
APA
Misson Mindrebo, L., Liu, H., Ozorowski, G., Tran, Q., Woehl, J., Khalek, I., Smith, J. M., Barman, S., Zhao, F., Keating, C., Limbo, O., Verma, M., Liu, J., Stanfield, R. L., Zhu, X., Turner, H. L., Sok, D., Huang, P. S., Burton, D. R., …, & Jardine, J. G. (2023). Fully synthetic platform to rapidly generate tetravalent bispecific nanobody–based immunoglobulins. Proceedings of the National Academy of Sciences, 120(24). https://doi.org/10.1073/pnas.2216612120
Vancouver
Misson Mindrebo L, Liu H, Ozorowski G, Tran Q, Woehl J, Khalek I, et al. Fully synthetic platform to rapidly generate tetravalent bispecific nanobody–based immunoglobulins. Proceedings of the National Academy of Sciences. 2023;120(24). doi:10.1073/pnas.2216612120
BibTeX
@article{MissonMindrebo2023,
author = {Misson Mindrebo, Laetitia and Liu, Hejun and Ozorowski, Gabriel and Tran, Quoc and Woehl, Jordan and Khalek, Irene and Smith, Jessica M and Barman, Shawn and Zhao, Fangzhu and Keating, Celina and Limbo, Oliver and Verma, Megan and Liu, Jingjia and Stanfield, Robyn L and Zhu, Xueyong and Turner, Hannah L and Sok, Devin and Huang, Po-Ssu and Burton, Dennis R and Ward, Andrew B and Wilson, Ian A and Jardine, Joseph G},
title = {Fully synthetic platform to rapidly generate tetravalent bispecific nanobody–based immunoglobulins},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {24},
doi = {10.1073/pnas.2216612120}
}
EUVIMED